{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:56:39Z","timestamp":1790423799777,"version":"4.1.0"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T00:00:00Z","timestamp":1572739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK077064"],"award-info":[{"award-number":["DK077064"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK089502"],"award-info":[{"award-number":["P30DK089502"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270468"],"award-info":[{"award-number":["81270468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870391"],"award-info":[{"award-number":["81870391"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Interleukin 6 [IL-6] or its receptor is currently a candidate for targeted biological therapy of inflammatory bowel disease [IBD]. Thus, a comprehensive understanding of the consequences of blocking IL-6 is imperative. We investigated this by evaluating the effects of IL-6 deletion on the spontaneous colitis of IL-10-deficient mice [IL-10\u2212\/\u2212].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>IL-6\/IL-10 double-deficient mice [IL-6\u2212\/\u2212\/IL-10\u2212\/\u2212] were generated and analysed for intestinal inflammation, general phenotypes and molecular\/biochemical changes in the colonic mucosa compared with wild-type and IL-10\u2212\/\u2212 mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Unexpectedly, the IL-6\u2212\/\u2212\/IL-10\u2212\/\u2212 mice showed more pronounced gut inflammation and earlier disease onset than IL-10\u2212\/\u2212 mice, both locally [colon and small bowel] and systemically [splenomegaly, ulcerative dermatitis, leukocytosis, neutrophilia and monocytosis]. IL-6\u2212\/\u2212\/IL-10\u2212\/\u2212 mice exhibited elevations of multiple cytokines [IL-1\u03b2, IL-4, IL-12, TNF\u03b1] and chemokines [MCP-1 and MIG], but not IFN-\u03b3 [Th1], IL-17A and IL-17G [Th17], or IL-22 [Th22]. FOXP3 and TGF-\u03b2, two key factors for regulatory T [Treg] cell differentiation, were significantly down-regulated in the colonic mucosa, but not in the thymus or mesenteric lymph nodes, of IL-6\u2212\/\u2212\/IL-10\u2212\/\u2212 mice. CTLA-4 was diminished while iNOS was up-regulated in the colonic mucosa of IL-6\u2212\/\u2212\/IL-10\u2212\/\u2212 mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In IL-10\u2212\/\u2212 mice, complete IL-6 blockade significantly aggravates gut inflammation, at least in part by suppressing Treg\/CTLA-4 and promoting the IL-1\u03b2\/Th2 pathway. In addition, the double mutant exhibits signs of severe systemic inflammation. Our data define a new function of IL-6 and suggest that caution should be exercised when targeting IL-6 in IBD patients, particularly those with defects in IL-10 signalling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjz176","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T08:12:57Z","timestamp":1572423177000},"page":"831-840","source":"Crossref","is-referenced-by-count":57,"title":["Deletion of IL-6 Exacerbates Colitis and Induces Systemic Inflammation in IL-10-Deficient Mice"],"prefix":"10.1093","volume":"14","author":[{"given":"Mei","family":"Ye","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA"},{"name":"Department of Gastroenterology, Zhongnan Hospital, Wuhan University, Hubei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E","family":"Joosse","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA"},{"name":"Department of Gastroenterology, West China Hospital, Sichuan University, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dong","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchun","family":"Cai","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenmei","family":"Song","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Zhang","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R","family":"Brant","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lazarev","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhang","family":"Li","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,3]]},"reference":[{"key":"2020070911142012900_CIT0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2020070911142012900_CIT0002","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/MIB.0000000000000750","article-title":"Current understanding of dysbiosis in disease in human and animal models","volume":"22","author":"DeGruttola","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2020070911142012900_CIT0003","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-pathol-012615-044152","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"11","author":"Liu","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"2020070911142012900_CIT0004","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1053\/j.gastro.2015.08.001","article-title":"Genetics of inflammatory bowel diseases","volume":"149","author":"McGovern","year":"2015","journal-title":"Gastroenterology"},{"key":"2020070911142012900_CIT0005","doi-asserted-by":"crossref","first-page":"E397","DOI":"10.3390\/cells8050397","article-title":"Controlling gut inflammation by restoring anti-inflammatory pathways in inflammatory bowel disease","volume":"8","author":"Giuffrida","year":"2019","journal-title":"Cells"},{"key":"2020070911142012900_CIT0006","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/gutjnl-2014-307916","article-title":"Compartment-specific immunity in the human gut: properties and functions of dendritic cells in the colon versus the ileum","volume":"65","author":"Mann","year":"2016","journal-title":"Gut"},{"key":"2020070911142012900_CIT0007","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/00365521.2014.966321","article-title":"The innate immune system and inflammatory bowel disease","volume":"50","author":"Davies","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"2020070911142012900_CIT0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.advms.2016.09.001","article-title":"Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease","volume":"62","author":"Kmie\u0107","year":"2017","journal-title":"Adv Med Sci"},{"key":"2020070911142012900_CIT0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"13","author":"Geremia","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2020070911142012900_CIT0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10620-017-4892-4","article-title":"Old and new lymphocyte players in inflammatory bowel disease","volume":"63","author":"Giuffrida","year":"2018","journal-title":"Dig Dis Sci"},{"key":"2020070911142012900_CIT0011","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol"},{"key":"2020070911142012900_CIT0012","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.4049\/jimmunol.0901528","article-title":"Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells","volume":"184","author":"Jones","year":"2010","journal-title":"J Immunol"},{"key":"2020070911142012900_CIT0013","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.0801217","article-title":"Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6\/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model","volume":"184","author":"Matsumoto","year":"2010","journal-title":"J Immunol"},{"key":"2020070911142012900_CIT0014","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2015.04.017","article-title":"Interleukin 6 increases production of cytokines by colonic innate lymphoid cells in mice and patients with chronic intestinal inflammation","volume":"149","author":"Powell","year":"2015","journal-title":"Gastroenterology"},{"key":"2020070911142012900_CIT0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/j.gastro.2018.05.022","article-title":"Variation in interleukin 6 receptor gene associates with risk of crohn\u2019s disease and ulcerative colitis","volume":"155","author":"Parisinos","year":"2018","journal-title":"Gastroenterology"},{"key":"2020070911142012900_CIT0016","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cytogfr.2006.09.003","article-title":"Interleukin-6 trans-signaling in inflammatory bowel disease","volume":"17","author":"Mitsuyama","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"2020070911142012900_CIT0017","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1111\/j.1572-0241.1999.01288.x","article-title":"Clinical relevance of serum interleukin-6 in Crohn\u2019s disease: single point measurements, therapy monitoring, and prediction of clinical relapse","volume":"94","author":"Reinisch","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"2020070911142012900_CIT0018","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000068150","article-title":"A new model of chronic colitis in SCID mice induced by adoptive transfer of CD62L+ CD4+ T cells: insights into the regulatory role of interleukin-6 on apoptosis","volume":"70","author":"Mudter","year":"2002","journal-title":"Pathobiology"},{"key":"2020070911142012900_CIT0019","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF03326415","article-title":"Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes T-cell apoptosis in a murine model of Crohn\u2019s disease","volume":"37","author":"Ito","year":"2002","journal-title":"J Gastroenterol"},{"key":"2020070911142012900_CIT0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/75068","article-title":"Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo","volume":"6","author":"Atreya","year":"2000","journal-title":"Nat Med"},{"key":"2020070911142012900_CIT0021","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cyto.2016.04.012","article-title":"Neutralization of IL-6 and TNF-\u03b1 ameliorates intestinal permeability in DSS-induced colitis","volume":"83","author":"Xiao","year":"2016","journal-title":"Cytokine"},{"key":"2020070911142012900_CIT0022","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","article-title":"Targeting interleukin-6 in inflammatory autoimmune diseases and cancers","volume":"141","author":"Yao","year":"2014","journal-title":"Pharmacol Ther"},{"key":"2020070911142012900_CIT0023","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-14-2291","article-title":"Interleukin-6 as a therapeutic target","volume":"21","author":"Rossi","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2020070911142012900_CIT0024","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF02990576","article-title":"Treatment of Crohn\u2019s disease with anti-IL-6 receptor antibody","volume":"40","author":"Ito","year":"2005","journal-title":"J Gastroenterol"},{"key":"2020070911142012900_CIT0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/gutjnl-2017-314562","article-title":"Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn\u2019s disease (ANDANTE I and II)","volume":"68","author":"Danese","year":"2019","journal-title":"Gut"},{"key":"2020070911142012900_CIT0026","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1600-6143.2004.00368.x","article-title":"Exogenous IL-6 inhibits acute inflammatory responses and prevents ischemia\/reperfusion injury after intestinal transplantation","volume":"4","author":"Kimizuka","year":"2004","journal-title":"Am J Transplant"},{"key":"2020070911142012900_CIT0027","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer Cell"},{"key":"2020070911142012900_CIT0028","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.4049\/jimmunol.180.10.6816","article-title":"IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching\/effacing lesion-forming enteric bacterial pathogens","volume":"180","author":"Dann","year":"2008","journal-title":"J Immunol"},{"key":"2020070911142012900_CIT0029","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/gut.2008.151175","article-title":"Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice","volume":"59","author":"Jin","year":"2010","journal-title":"Gut"},{"key":"2020070911142012900_CIT0030","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","article-title":"Inflammatory bowel disease and mutations affecting the interleukin-10 receptor","volume":"361","author":"Glocker","year":"2009","journal-title":"N Engl J Med"},{"key":"2020070911142012900_CIT0031","doi-asserted-by":"crossref","first-page":"G734","DOI":"10.1152\/ajpgi.2000.278.5.G734","article-title":"Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice","volume":"278","author":"Kawachi","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2020070911142012900_CIT0032","first-page":"737","article-title":"The pathogenic role of NLRP3 inflammasome activation in inflammatory bowel diseases of both mice and humans","volume":"11","author":"Liu","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2020070911142012900_CIT0033","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.4049\/jimmunol.0901657","article-title":"Clcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis","volume":"184","author":"Alex","year":"2010","journal-title":"J Immunol"},{"key":"2020070911142012900_CIT0034","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ibd.20753","article-title":"Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis","volume":"15","author":"Alex","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2020070911142012900_CIT0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12721","article-title":"What did we learn from CTLA-4 insufficiency on the human immune system?","volume":"287","author":"Mitsuiki","year":"2019","journal-title":"Immunol Rev"},{"key":"2020070911142012900_CIT0036","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1038\/ctg.2013.17","article-title":"Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease","volume":"5","author":"Dhillon","year":"2014","journal-title":"Clin Transl Gastroenterol"},{"key":"2020070911142012900_CIT0037","first-page":"670","article-title":"Enteral immunotherapy in the treatment of chronic enterocolitis in interleukin-10-deficient mice","volume":"50","author":"Glehen","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"2020070911142012900_CIT0038","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.4049\/jimmunol.165.9.5227","article-title":"Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways","volume":"165","author":"Ahmed","year":"2000","journal-title":"J Immunol"},{"key":"2020070911142012900_CIT0039","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/43206","article-title":"A family of cytokine-inducible inhibitors of signalling","volume":"387","author":"Starr","year":"1997","journal-title":"Nature"},{"key":"2020070911142012900_CIT0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V83.1.113.113","article-title":"Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55","volume":"83","author":"Tilg","year":"1994","journal-title":"Blood"},{"key":"2020070911142012900_CIT0041","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.7150\/ijbs.4874","article-title":"Role of IL-6 in asthma and other inflammatory pulmonary diseases","volume":"8","author":"Rincon","year":"2012","journal-title":"Int J Biol Sci"},{"key":"2020070911142012900_CIT0042","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.kint.2016.12.014","article-title":"Circulating IL-6 upregulates IL-10 production in splenic CD4+ T cells and limits acute kidney injury-induced lung inflammation","volume":"91","author":"Andres-Hernando","year":"2017","journal-title":"Kidney Int"},{"key":"2020070911142012900_CIT0043","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.01.002","article-title":"gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis","volume":"15","author":"Bollrath","year":"2009","journal-title":"Cancer Cell"},{"key":"2020070911142012900_CIT0044","doi-asserted-by":"crossref","first-page":"e114195","DOI":"10.1371\/journal.pone.0114195","article-title":"IL-6 stimulates intestinal epithelial proliferation and repair after injury","volume":"9","author":"Kuhn","year":"2014","journal-title":"PLoS One"},{"key":"2020070911142012900_CIT0045","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3748\/wjg.14.4280","article-title":"Role of cytokines in inflammatory bowel disease","volume":"14","author":"Sanchez-Munoz","year":"2008","journal-title":"World J Gastroenterol"},{"key":"2020070911142012900_CIT0046","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"2020070911142012900_CIT0047","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.autrev.2014.10.012","article-title":"Regulatory T-cells in autoimmune diseases: challenges, controversies and-yet-unanswered questions","volume":"14","author":"Grant","year":"2015","journal-title":"Autoimmun Rev"},{"key":"2020070911142012900_CIT0048","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"2020070911142012900_CIT0049","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","article-title":"Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation","volume":"34","author":"Chaudhry","year":"2011","journal-title":"Immunity"},{"key":"2020070911142012900_CIT0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"2020070911142012900_CIT0051","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur J Immunol"},{"key":"2020070911142012900_CIT0052","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clim.2008.08.018","article-title":"The effects of IL-6 on CD4 T cell responses","volume":"130","author":"Dienz","year":"2009","journal-title":"Clin Immunol"},{"key":"2020070911142012900_CIT0053","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2174\/1566524043359908","article-title":"The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all?","volume":"4","author":"Suschek","year":"2004","journal-title":"Curr Mol Med"},{"key":"2020070911142012900_CIT0054","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0016-5085(96)70055-0","article-title":"Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease","volume":"111","author":"Singer","year":"1996","journal-title":"Gastroenterology"},{"key":"2020070911142012900_CIT0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.45.3.367","article-title":"Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP","volume":"45","author":"Cavicchi","year":"1999","journal-title":"Gut"},{"key":"2020070911142012900_CIT0056","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1742-4658.2004.04484.x","article-title":"Polarized distribution of inducible nitric oxide synthase regulates activity in intestinal epithelial cells","volume":"272","author":"Rumbo","year":"2005","journal-title":"FEBS J"},{"key":"2020070911142012900_CIT0057","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1073\/pnas.0812347106","article-title":"Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice","volume":"106","author":"Erdman","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020070911142012900_CIT0058","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1189\/jlb.0802397","article-title":"Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice","volume":"73","author":"Lin","year":"2003","journal-title":"J Leukoc Biol"},{"key":"2020070911142012900_CIT0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpam.2019.02.002","article-title":"Current concepts in pediatric inflammatory bowel disease; IL10\/IL10R colitis as a model disease","volume":"6","author":"Almana","year":"2019","journal-title":"Int J Pediatr Adolesc Med"},{"key":"2020070911142012900_CIT0060","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1172\/JCI57158","article-title":"Therapeutic strategies for the clinical blockade of IL-6\/gp130 signaling","volume":"121","author":"Jones","year":"2011","journal-title":"J Clin Invest"},{"key":"2020070911142012900_CIT0061","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coi.2015.02.008","article-title":"The IL-6\/gp130\/STAT3 signaling axis: recent advances towards specific inhibition","volume":"34","author":"Garbers","year":"2015","journal-title":"Curr Opin Immunol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjz176\/30343052\/jjz176.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/14\/6\/831\/33478936\/jjz176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/14\/6\/831\/33478936\/jjz176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T11:14:59Z","timestamp":1594293299000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/14\/6\/831\/5611236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,3]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,11,3]]},"published-print":{"date-parts":[[2020,7,9]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz176","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2019,11,3]]}}}